| Asepsis | | internal radiation implantation |
| Chronic | | study of cancer |
| Metastasis | | always present in the country |
| Thrombocytopenia | | causes tissue necrosis and damage |
| Malignant | | hair loss |
| Vesicant | | lacking normal cellular characteristics |
| Neoplasia | | malignant transformation |
| Pandemic | | muscle wasting |
| Endemic | | strength of the microorganism |
| Stomatitis | | uncontrolled cell growth that follows no physiologic demand |
| Alopecia | | bizarre cell growth |
| Oncology | | abnormally low absolute neutrophil count |
| Toxigenicity | | body where the microorganism multiply |
| Virulence | | dry oral cavity |
| Metaplasia | | relief of symptoms associated with cancer |
| Biopsy | | time period that is waited until infection is noticed |
| Anaplasia | | ability to produce toxin |
| Brachytherapy | | killing the microorganism |
| Epidemic | | diagnostic test for cancer |
| Ecologic model | | inflammation of the oral tissues |
| Antigenicity | | infection/causative agents last for more than 6 months |
| TSA | | determines the size of the tumor and existence of metastasis |
| Disinfection | | graft-versus-host disease |
| Extravasation | | conversion of one mature cell to other type |
| Apoptosis | | to resist antibody-antigen complexes |
| Staging | | increase in the number of tissue cells |
| Skin | | protein on the membrane of cancer cells |
| Neutropenia | | spread of cancer cells |
| Convalescent | | the study of distribution of diseases, both communicable and non-communicable as well as any accident |
| Incubation | | decrease circulating platelets |
| Cachexia | | remission |
| Dysplasia | | having cells that are characteristics of cancer |
| Sporadic | | nationwide epidemic |
| Hyperplasia | | scattered, or occurring at an irregular intervals or few places |
| Reservoir | | maintain sterility and/or cleanliness |
| Epidemiology | | shows the relationship bet. the agent, host, and environment |
| Palliation | | first line defense mechanism |
| Carcinogenesis | | leakage of medication from the veins into the subcutaneous tissue |
| Xerostemia | | sharp increase in the number of affected |
| GVHD | | programmed cell death |